Searchable abstracts of presentations at key conferences in endocrinology

ea0016p647 | Reproduction | ECE2008

Nonalcoholic fatty liver disease in women with polycystic ovary syndrome

Vassilatou Evangeline , Lafoyianni Sophia , Tsarouhas Kostantine , Papavassileiou Stathis , Tzavara Ioanna

Background: Nonalcoholic fatty liver disease (NAFLD) has been associated with insulin resistance. As polycystic ovary syndrome (PCOS) is also associated with insulin resistance, the presence of NAFLD has been investigated in patients with the syndrome and there are data showing an increased prevalence of abnormal aminotransferance activity and/or ultrasonographic evidence of hepatic steatosis.Objective: In the present prospective study women with PCOS we...

ea0049ep1139 | Female Reproduction | ECE2017

Diagnostic performance of non-invasive markers for the presence of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome

Vassilatou Evangeline , Lafoyianni Sophia , Vassiliadi Dimitra-Argyro , Ioannidis Dimitrios , Paschou Stavroula , Mizamtzidi Maria , Vryonidou Andromachi

Introduction: Several markers based on anthropometric and biochemical parameters like fatty liver index (FLI), lipid accumulation product (LAP) index and visceral adiposity index (VAI), have been proposed for the detection of nonalcoholic fatty liver disease (NAFLD).Objective: To evaluate the diagnostic performance of FLI, LAP and VAI as markers of NAFLD in premenopausal women with and without polycystic ovary syndrome (PCOS), assessed for hepatic steato...

ea0041ep822 | Obesity | ECE2016

Visceral adiposity index as a marker of hepatic steatosis in overweight and obese premenopausal women

Vassilatou Evangeline , Vassiliadi Dimitra , Lazaridou Helen , Koutsomitopoulos Nikitas , Kelekis Nikolaos , Hadjidakis Dimitrios , Dimitriadis George

Introduction: Visceral adiposity index (VAI), initially developed as an indicator of visceral adipose function for the assessment of cardiometabolic risk, has been also proposed for the detection of nonalcoholic fatty liver disease (NAFLD). However, the diagnostic performance of VAI as a marker of hepatic steatosis (HS) is still under investigation.Objective: To evaluate the accuracy of VAI as a marker of HS in a cohort of overweight and obese premenopau...

ea0035p629 | Female reproduction | ECE2014

Birth weight is associated with important clinical and biochemical parameters of PCOS

Paschou Stavroula A. , Ioannidis Dimitrios , Vassilatou Evangeline , Panagou Maria , Lilis Dimitrios , Tzavara Ioanna , Vryonidou Andromachi

Introduction: Several studies have demonstrated associations of birth weight with metabolic and reproductive abnormalities in adults. The aim of this study was to investigate the birth weight in women with PCOS and its correlation with important clinical and biochemical parameters of the syndrome.Patients and methods: We studied 288 women with PCOS according to the NIH criteria (1990) and 166 women with normal cycles and without clinical or biochemical h...

ea0020p91 | Thyroid | ECE2009

Evaluation of chronic urticaria in patients with autoimmune thyroid disease

Vassilatou Evangeline , Hadjidakis Dimitrios , Mellios Anagnostis , Makris Michael , Chliva Ekaterini , Economopoulos Theophanis , Kalogeromitros Dimitrios

Background: Chronic urticaria (CU) is defined as recurrent episodes of hives with or without angioedema of at least 6 weeks’ duration; in almost 40% of the cases an underlying autoimmune process is implicated. Increased prevalence of autoimmune thyroid disease (ATD) has been reported in patients with CU, however the clinical significance of this finding remains controversial. Moreover, data concerning the prevalence of CU in patients with ATD are few.<p class="abstext...

ea0016p53 | Adrenal | ECE2008

Subclinical autonomous cortisol hypersecretion by adrenal incidentalomas may be intermittent: results from a long term follow-up study

Vassilatou Evangeline , Michalopoulou Stamatia , Vryonidou Andromachi , Manolis John , Panayiotopoulos Constantine , Tzavara Ioanna

Background: Hormonal studies have detected subtle abnormalities of the hypothalamic–pituitary–adrenal (HPA) axis due to autonomous cortisol secretion, in a percentage of patients with adrenal incidentalomas, a condition termed as subclinical Cushing’s syndrome. The diagnostic criteria and the clinical significance of this condition are still controversial and consequently there is uncertainty for its management. Data defining the natural course of these tumors, ...

ea0037ep303 | Calcium and Vitamin D metabolism | ECE2015

Fragility fractures as the initial manifestation of indolent systemic mastocytosis

Vassilatou Evangeline , Gavoyiannakis Nickolas , Chatzipetrou Alexia , Koulias Christoforos , Makris Michael , Garoflos Eustathios , Hadjidakis Dimitrios , Rigopoulos Dimitrios , Dimitriadis George

Introduction: Systemic mastocytosis (SM) is a rare disorder characterised by clonal proliferation of abnormal mast cells in several tissues, most often skin and bone marrow. Indolent systemic mastocytosis (ISM) is the commonest disease variant in adults, characterised by very low rate of mast cell proliferation. SM has been recognised as a cause of secondary osteoporosis.Objective: To evaluate bone mineral density and fragility fractures in ISM patients....